| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |